Abstract
A 3.5-month-old infant with undiagnosed underlying combined immunodeficiency presented with S. ceravisiae fungemia following treatment with S. boulardii containing probiotic preparation. This case highlights that the use of probiotics in sick patients may be fraught with danger.
References
Shashidhar A, Suman Rao PN, Nesarga S, Bhat S, Chandrakala BS. Probiotics for promoting feed tolerance in very low birth weight neonates - A randomized controlled trial. Indian Pediatr. 2017;54:363–7
Serkan A, Ahmet S, Kivilcim KC, Serife YI, Burak A, Gursu K, et al. Catheter related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic treatment: In a child in intensive care unit and review of literature. Med Mycol Case Rep. 2017;15:33–5
McCullough MJ, Clemons KV, McCusker JH, Stevens DA. Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). J Clin Microbiol. 1998;36:2613–7
Thygesen J, Glerup H, Tarp B. Saccharomyces boulardii fungemia caused by treatment with a probioticum. Case Reports. 2012;2012:bcr0620114412-bcr0620114412
Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer. 2000;8:504–5
Szajewska H, Canani R, Guarino A, Hojsak I, Indrio F, Kolacek S, et al. Probiotics for the prevention of antibioticassociated diarrhea in children. J Pediatr Gastroenterol Nutr. 2016;62:495–506.
Funding
Funding None; Competing interest: None stated.
Author information
Authors and Affiliations
Contributions
Contributors: All authors were involved in clinical management of the patient and writing of the manuscript.
Corresponding author
Rights and permissions
About this article
Cite this article
Chakravarty, S., Parashar, A. & Acharyya, S. Saccharomyces cerevisiae Sepsis Following Probiotic Therapy in an Infant. Indian Pediatr 56, 971–972 (2019). https://doi.org/10.1007/s13312-019-1655-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-019-1655-7